Clene Inc.
USD6.12
-0.22 (-3.47%)
CEO
Robert Etherington
IPO Date
2018-10-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.29
Prev. Close
$6.33
Day Low
$6.07
Day High
$6.38
52W Low
$3.25
52W High
$13.50
Market Cap
$0.06B
Volume
0.03M
| -0.9 |
| 31 Dec 2023 | FY | 81.5% | -7569.4% | -369.7% | -94.6% | 2.40 | 1.53 | -0.6 |
| 31 Dec 2022 | FY | 94.5% | -6325.2% | -924.3% | -67.2% | 9.83 | 2.11 | -2.2 |
| 31 Dec 2021 | FY | 60.0% | -1347.2% | -77.3% | -15.4% | 1.91 | 9.06 | -25.9 |
| 31 Dec 2020 | FY | 68.4% | -9357.8% | -5653.1% | -28.2% | 12.68 | 5.40 | -32.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -330.6% | -108.6% | 0.59 | 2.20 | -45.0 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -5.5% | -0.6% | 0.64 | 3.56 | -2227.7 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -254888.5 |
| -1.6 |
| 30 Sept 2025 | Q3 | 100.0% | -58513.3% | 71.0% | -39.3% | -1.72 | 1.53 | -1.8 |
| 30 Jun 2025 | Q2 | 100.0% | -27477.8% | 86.8% | -33.5% | -2.44 | 1.58 | -1.3 |
| 31 Mar 2025 | Q1 | 75.3% | -927.2% | 15.1% | -3.0% | -4.21 | 1.36 | -9.0 |
| 31 Dec 2024 | Q4 | 80.2% | -14889.0% | 153.0% | -49.6% | -2.35 | 1.57 | -0.7 |
| 30 Sept 2024 | Q3 | 79.3% | -9179.3% | 193.6% | -25.3% | -5.55 | 0.83 | -0.9 |
| 30 Jun 2024 | Q2 | 80.2% | -7456.0% | 1346.2% | -16.8% | -65.96 | 0.99 | -1.7 |
| 31 Mar 2024 | Q1 | 78.1% | -15178.1% | -259.8% | -24.6% | 7.61 | 1.23 | -1.2 |
| 31 Dec 2023 | Q4 | -170.6% | -5984.1% | -76.0% | -19.4% | 2.40 | 1.53 | -0.9 |